Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 95 entries
View as:

A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00865657 Org: User:
Start: 09/30/05 End: 09/30/05 Due: 09/30/06

A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Non-fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00864305 Org: User:
Start: 12/31/97 End: 01/31/98 Due: 01/31/99

Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 110 mcg

Phase: N/A Priority: Normal
NCT ID: NCT03879837 Org: User:
Start: 03/25/19 End: 07/09/21 Due: 07/09/22

Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03756883 Org: User:
Start: 12/03/18 End: 11/10/19 Due: 11/10/20

A Relative Bioavailability Study of 60 mg Nifedipine Extended Release Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00865891 Org: User:
Start: 07/31/05 End: 07/31/05 Due: 07/31/06

A Relative Bioavailability Study of Fentanyl 25 μg/h Transdermal System

Phase: N/A Priority: Normal
NCT ID: NCT00864565 Org: User:
Start: 06/30/03 End: 06/30/03 Due: 06/30/04

A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT02654769 Org: User:
Start: 02/28/15 End: 09/30/15 Due: 09/30/16

A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses

Phase: N/A Priority: Normal
NCT ID: NCT02120898 Org: User:
Start: 10/10/13 End: 04/30/14 Due: 04/30/15

Clinical Endpoint Study of Ivermectin 1% Cream

Phase: N/A Priority: Normal
NCT ID: NCT02840461 Org: User:
Start: 06/30/16 End: 12/31/16 Due: 12/31/17

A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00865410 Org: User:
Start: 08/31/04 End: 09/30/04 Due: 09/30/05

A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00864058 Org: User:
Start: 01/31/98 End: 01/31/98 Due: 01/31/99

Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes

Phase: N/A Priority: Normal
NCT ID: NCT02512042 Org: User:
Start: 04/30/15 End: 05/31/16 Due: 05/31/17

A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00870142 Org: User:
Start: 04/30/05 End: 05/31/05 Due: 05/31/06

A Relative Bioavailability Study of 60 mg Nifedipine ER Tablets Under Non-fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00864617 Org: User:
Start: 05/31/05 End: 05/31/05 Due: 05/31/06

Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00759915 Org: User:
Start: 08/31/06 End: 10/31/06 Due: 10/31/07

Clinical Endpoint Study of Ivermectin 0.5% Lotion

Phase: N/A Priority: Normal
NCT ID: NCT03301649 Org: User:
Start: 10/07/17 End: 03/12/18 Due: 03/12/19

A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00863863 Org: User:
Start: 01/31/06 End: 01/31/06 Due: 01/31/07

A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00870480 Org: User:
Start: 11/30/04 End: 11/30/04 Due: 11/30/05

Single Dose Two-Way Crossover Fed Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00864604 Org: User:
Start: 04/30/07 End: 05/31/07 Due: 05/31/08

A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00864071 Org: User:
Start: 11/30/05 End: 11/30/05 Due: 11/30/06

A Study of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT02495857 Org: User:
Start: 08/15/15 End: 12/05/16 Due: 12/05/17

A Limited Food Effect Study of Gabapentin 800 mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00865631 Org: User:
Start: 06/30/99 End: 06/30/99 Due: 06/30/00

A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00871247 Org: User:
Start: 11/30/04 End: 11/30/04 Due: 11/30/05

Pivotal Bioequivalence Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00865605 Org: User:
Start: 12/31/03 End: 07/31/04 Due: 07/31/05

A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Non-fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00864019 Org: User:
Start: 08/31/04 End: 08/31/04 Due: 08/31/05